Glycemic, lipid, anthropometric and body composition responses to two Mango varieties versus white bread in people with type 2 diabetes: an 8-week randomised controlled trial

两种芒果品种与白面包对2型糖尿病患者血糖、血脂、人体测量学指标和身体成分的影响:一项为期8周的随机对照试验

阅读:2

Abstract

Limited scientific evidence exists regarding the impact of mangoes on glycemic control in people with type 2 diabetes (T2D). This randomized controlled trial assessed the effects of 8 weeks consumption of 250 gram/day of two popular Indian mango varieties (Safeda and Dasheri) compared to bread intake on glycemia, anthropometry and lipids in individuals with T2D. The study enrolled 35 participants with T2D, dividing them into three groups: Safeda mango (n = 10), Dasheri mango (n = 10), and bread as controls (n = 15), monitoring glycemic parameters, insulin sensitivity, anthropometric measurements (including 7 skinfolds), body composition measurement and lipid profile. Both mango varieties demonstrated significant improvements compared to bread in multiple parameters, with the Safeda and Dasheri groups showing fasting blood glucose reductions of 26.9 mg/dL (mango alone -7 mg/dL) and 36.1 mg/dL (mango alone -18.7 mg/dL), while glycosylated haemoglobin (HbA1c) decreased by 0.9% (bread +0.3% vs mango -0.6) and 0.5% (bread +0.3% vs mango -0.2%), and homeostatic model assessment of insulin resistance (HOMA-IR) decreased by 1.7 and 1.2, respectively, with reference to bread. Blood glucose values by self-monitoring decreased in mango group at all four time points, while body weight and total skinfolds decreased in both mango groups by 2.4 kg (bread +1.9 kg vs mango -0.5 kg) (Safeda) and 2.1 kg (bread +1.9 kg vs mango -0.4 kg) (Dasheri), and 17.7 mm (Safeda) and 20 mm (Dasheri), respectively, with reference to bread. Waist circumference showed significant reduction in mango groups compared to bread group. High-density lipoprotein cholesterol (HDL-C) increased significantly in both mango groups. To summarise, regular consumption of Safeda and Dasheri mangoes instead of bread in breakfast, in a measured and controlled manner as a part of calorie restrictive diet, improved glycemic control, weight, waist circumference,, skinfold thickness, insulin sensitivity and HDL-C in T2D subjects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40200-025-01690-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。